Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9358-9365

  Bouyac, Michèle ^a   Courcoul, Marianne ^a   Bertoia, Gilles ^a   Baudat, Yves ^a   Gabuzda, Dana ^c   Blanc, Dominique ^a,d   Chazal, Nathalie ^b   Boulanger, Pierre ^b   Sire, Joséphine ^a   Vigne, Robert ^a   Spire, Bruno ^a  

^a INSERM   (France)

^b Laboratoire de Biochimie Genetique   (France)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d CIRBS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GAG PROTEIN; GLUTATHIONE TRANSFERASE; PROTEIN PRECURSOR; VIF PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; PERIPHERAL LYMPHOCYTE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0030812551     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9358-9365.1997     Document Type: Article

References (49)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Agostini, I., J. M. Navarro, F. Rey, M. Bouhamdan, B. Spire, R. Vigne, and J. Sire. 1996. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261:599-606.
3. Benichou, S., M. Bomsel, M. Bodeus, H. Durand, M. Doute, F. Letourneur, J. Camonis, and R. Benarous. 1994. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269:30073-30076.
4. - HIV-1 mutants in CEM cells suggests that Vif affects late steps of the viral life cycle. Virology 193:186-192.
5. - mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69: 2058-2067.
6. Bouhamdan, M., S. Benichou, F. Rey, J. M. Navarro, I. Agostini, B. Spire, J. Camonis, G. Slupphaug, R. Vigne, R. Benarous, and J. Sire. 1996. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:697-704.
7. - human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71:2473-2477.
8. Camaur, D., and D. Trono. 1996. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:6106-6111.
9. Carriere, C., B. Gay, N. Chazal, N. Morin, and P. Boulanger. 1995. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. J. Virol. 69:2366-2377.
10. Chazal, N., B. Gay, C. Carriere, J. Tournier, and P. Boulanger. 1995. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. J. Virol. 69:365-375.
11. Cosson, P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:5783-5788.
12. - human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
13. Desrosiers, R. C. 1992. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res. Hum. Retroviruses 8:411-421.
14. Fan, L., and K. Peden. 1992. Cell-free transmission of Vif mutants of HIV-1. Virology 190:19-29.
15. Fisher, A. G., E. Collalti, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1985. A molecular clone of HTLV-III with biological activity. Nature 316:262-265.
16. Fouchier, R. A. M., J. H. M. Simon, A. B. Jaffe, and M. H. Malim. 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of Gag, Pol, and Env encoded proteins. J. Virol. 70: 8263-8269.
17. + T lymphocytes. J. Virol. 66:6489-6495.
18. Gabuzda, D. H., H. Li, K. Lawrence, B. S. Vasir, K. Crawford, and E. Langhoff. 1994. Essential role of Vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J. Acquired Immune Defic. Syndr. 7:908-915.
19. Goncalves, J., P. Jallepalli, and D. H. Gabuzda. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J. Virol. 68:704-712.
20. Goncalves, J., Y. Korin, J. Zack, and D. Gabuzda. 1996. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70: 8701-8709.
21. Goncalves, J., B. Shi, X. Y. Yang, and D. Gabuzda. 1995. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J. Virol. 69:7196-7204.
22. Greenway, A., A. Azad, J. Mills, and D. McPhee. 1996. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70:6701-6708.
23. Harmache, A., P. Russo, F. Guiguen, C. Vitu, M. Vignoni, M. Bouyac, C. Hiéblot, J. F. Mornex, M. Pepin, R. Vigne, and M. Suzan. 1996. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 224:246-255.
24. Hawley-Nelson, P., V. Ciccarone, G. Gebeyehu, J. Jessee, and P. H. Felgner. 1993. Lipofectamine reagent: a new, highly efficiency polycationic liposome transfection reagent. Focus 15:73-79.
25. Hoglund, S., A. Ohagen, K. Lawrence, and D. Gabuzda. 1994. Role of Vif during packing of the core of HIV-1. Virology 201:349-355.
26. Karczewski, M. K., and K. Strebel. 1996. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:494-507.
27. Lee, T. H., J. E. Coligan, J. S. Allan, M. F. McLane, J. E. Groopman, and M. Essex. 1986. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546-1549.
28. Li, M. S., G. Garcia-Asua, U. Bhattacharyya, P. Mascagni, B. M. Austen, and M. M. Roberts. 1996. The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro. Biochem. Biophys. Res. Commun. 218:352-355.
29. Liu, H. M., X. Y. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:7630-7638.
30. Luban, J., K. L. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
31. Oberste, M. S., and M. A. Gonda. 1992. Conservation of amino acid sequence motifs in lentivirus Vif proteins. Virus Genes 6:95-102.
32. Ottmann, M., C. Gabus, and J. L. Darlix. 1995. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69:1778-1784.
33. Reicin, A. S., A. Ohagen, L. Yin, S. Hoglund, and S. P. Goff. 1996. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J. Virol. 70:8645-8652.
34. Rey, M. A., B. Spire, D. Dormont, F. Barre-Sinoussi, L. Montagnier, and J. C. Chermann. 1984. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem. Biophys. Res. Commun. 121:126-133.
35. Sakai, H., R. Shibata, J. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1666.
36. Sato, A., J. Yoshimoto, Y. Isaka, S. Miki, A. Suyama, A. Adachi, M. Hayami, T. Fujiwara, and O. Yoshie. 1996. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. Virology 220:208-212.
37. Simm, M., M. Shahabuddin, W. Chao, J. S. Allan, and D. J. Volsky. 1995. Aberrant Gag protein composition of a human immunodeficiency virus type 1 Vif mutant produced in primary lymphocytes. J. Virol. 69:4582-4586.
38. Simon ,J. H. M., R. A. M. Fouchier, T. E. Southerling, C. B. Guerra, C. K. Grant, and M. H. Malim. 1997. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol. 71:5259-5267.
39. Simon, J. H. M., and M. H. Malim. 1996. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70:5297-5305.
40. Simon, J. H. M., T. E. Southerling, J. C. Peterson, B. E. Meyer, and M. H. Malim. 1995. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69:4166-4172.
41. Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
42. Spire, B., J. Sire, V. Zachar, F. Rey, F. Barre-Sinoussi, F. Galibert, A. Hampe, and J. C. Chermann. 1989. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene 81:275-284.
43. Sutter, G., M. Ohlmann, and V. Erfle. 1995. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 371:9-12.
44. Tanchou, V., T. Delaunay, M. Bodeus, B. Roques, J. L. Darlix, and R. Benarous. 1995. Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein NCp7 and its precursor NCp15 as detected by anti-NCp7 monoclonal antibodies. J. Gen. Virol. 76:2457-2466.
45. Turelli, P., G. Petursson, F. Guiguen, J. F. Mornex, R. Vigne, and G. Quérat. 1996. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J. Virol. 70:1213-1217.
46. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
47. Wain Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell 40:9-17.
48. Wyatt, L. S., B. Moss, and S. Rozenblatt. 1995. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210:202-205.
49. Yang, X., J. Goncalves, and D. Gabuzda. 1996. Phosphorylation of Vif and its role in HIV-1 replication. J. Biol. Chem. 271:10121-10129.